CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ARWR

ARO-DM1 Intravenous (IV) Infusion

Phase 2
Arrowhead Pharmaceuticals, Inc. (ARWR)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
SRPTPhase 2

SRP-1003 IV Infusion Phase 2 Est. Readout

ARO-DM1 Intravenous (IV) Infusion
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Myotonic Dystrophy 1

View Full Landscape
Drug Information

Target Indication

Myotonic Dystrophy 1

Clinical Trial

NCT06138743

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.